Treatment of neurosyphilis

Current Treatment Options in Neurology

Volumn 8, Issue 3, 2006, Pages 185-192

  Jay, Cheryl A ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CARBAMAZEPINE; CEFTRIAXONE; CEPHALOSPORIN; CORTICOSTEROID DERIVATIVE; MACROLIDE; METHOTREXATE; PENICILLIN G; PHENYTOIN; PREDNISONE; PROBENECID; PROCAINE PENICILLIN; PROTEINASE INHIBITOR; SULFANILAMIDE; ZALCITABINE;

ABSCESS; ANAPHYLAXIS; BACTERIUM CULTURE; BONE MARROW SUPPRESSION; BRAIN DISEASE; CANADA; CARDIOPULMONARY INSUFFICIENCY; CEREBROSPINAL FLUID EXAMINATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; CRANIAL NEUROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG COST; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG POTENTIATION; ENCEPHALITIS; EOSINOPHILIA; EPIDEMIC; EUROPE; EYE DISEASE; HEADACHE; HEMOLYTIC ANEMIA; HERXHEIMER REACTION; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKALEMIA; IN VITRO STUDY; INCIDENCE; INFECTION RATE; INJECTION SITE REACTION; INTERSTITIAL NEPHRITIS; LACTIC ACIDOSIS; LIVER FAILURE; MANIA; MENINGITIS; MYALGIA; NEPHROTOXICITY; NEUROSYPHILIS; NEUTROPENIA; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIMARY INFECTION; PSEUDOMEMBRANOUS COLITIS; PSYCHOSIS; RADICULOPATHY; REVIEW; SEIZURE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEXUAL BEHAVIOR; SPINAL CORD DISEASE; SPINE DISEASE; STEVENS JOHNSON SYNDROME; SUPERINFECTION; SYMPTOMATOLOGY; SYPHILIS; TABES DORSALIS; THROMBOCYTOPENIA; TREATMENT FAILURE; TREPONEMA PALLIDUM; ULCER; UNITED STATES; VIRUS TRANSMISSION;

EID: 33645816139     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0009-7     Document Type: Review

References (36)

1. Peterman TA, Heffelfinger JD, Swint EB, Groseclose SL: The changing epidemiology of syphilis. Sex Transm Dis 2005, 32(Suppl 10):S4-S10.
2. Marra CM: Syphilis and human immunodeficiency virus-prevention and politics. Arch Neurol 2004, 61:1505-1508.
3. Centers for Disease Control and Prevention: Primary and secondary syphilis-United States, 2002. MMWR Morb Mortal Wkly Rep 2003, 52:1117-1120.
4. Hook EW, Peeling RW: Syphilis control-a continuing challenge. N Engl J Med 2004, 351:122-124.
5. San Francisco Department of Public Health: San Francisco sexually transmitted disease annual report, 2004. http://www.dph.sf.ca.us/reports/std/sfstdannlsum2004.pdf. Accessed December 11, 2005.
6. Zellan J, Augenbraun M: Syphilis in the HIV-infected patient: an update on epidemiology, diagnosis, and management. Curr HIV/AIDS Rep 2004, 1:142-147.
7. Buchacz K, Patel P, Taylor M, et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004, 18:2075-2079.
8. Lynn WA, Lightman S: Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004, 4:456-466.
9. Golden MR, Marra CM, Holmes KK: Update on syphilis: resurgence of an old problem. JAMA 2003, 290:1510-1514.
10. Zeltzer R, Kurban AK: Syphilis. Clin Dermatol 2004, 22:461-468.
11. Marra CM: Neurosyphilis. Curr Neurol Neurosci Rep 2004, 4:435-440.
12. Lukeheart SA, Hook EW, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855-962.
13. Rolfs RT, Joesoef MP, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997, 337:307-314.
14. O'Donnell JA, Emery CL: Neurosyphilis: a current review. Curr Infect Dis Rep 2005, 7:277-284.
15. Timmermans M, Carr J: Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatr 2004, 75:1727-1730.
16. Kiss S, Damico FM, Young LH: Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20:161-167.
17. Pletcher SD, Cheung SW: Syphilis and otolaryngology. Otolaryngol Clin N Am 2003, 36:595-605.
18. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002, 51:18-30.
19. Chan DJ: Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 2005, 3:95-98.
20. Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369-376.
21. Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001-1006.
22. Marra CM, Boutin P, McArthur JC, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000, 30:540-544.
23. Marra CM, Tantalo LC, Maxwell CL, et al.: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004, 63:85-88.
24. Parkes R, Renton A, Meheus A, Laukamm-Josten U: Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 2004, 15:73-88.
25. Centers for Disease Control and Prevention: Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medical Association/Infectious Diseases Society of North America. MMWR Morb Mortal Wkly Rep 2004, 53:27-30.
26. Ali L, Roos KL: Antibacterial therapy of neurosyphilis: lack of impact of new therapies. CNS Drugs 2002, 16:799-802.
27. Klasco RK: DRUGDEX® System. Greenwood Village, CO: Thomsom Micromedex; 2005.
28. Silberstein P, Lawrence R, Pryor D, Shnier R: A case of neurosyphilis with a florid Jarisch-Herxheimer reaction. J Clin Neurosci 2002, 9:689-690.
29. Pao D, Goh BT, Bingham JS: Management issues in syphilis. Drugs 2002, 62:1447-1461.
30. Centers for Disease Control and Prevention: Inadvertent use of Bicillin-CR to treat syphilis infection-Los Angeles, California, 1999-2004. MMWR Morb Mortal Wkly Rep 2005, 54:217-219.
31. Mullin P, Green G, Bakshi R: Special populations: the management of seizures in HIV-positive patients. Curr Neurol Neurosci Rep 2004, 4:308-314.
32. Lim ML, Min SS, Eron JJ, et al.: Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P450 induction. J Acquir Immune Defic Syndr 2004, 36:1034-1040.
33. Hugen PWH, Burger DM, Brinkman K, et al.: Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother 2000, 34:465-470.
34. Smith NH, Musher DM, Huang DB, et al.: Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15:328-332.
35. Centers for Disease Control and Prevention: Brief report: azithromycin treatment failures in syphilis infections-San Francisco, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2004, 53:197-198.
36. Lukehart SA, Godornes C, Molini BJ, et al.: Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004, 251:154-158.